Reply to Hein V. Stroomberg, Klaus Brasso, and Andreas Røder’s Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging–visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003
-
Published:2024-09
Issue:3
Volume:86
Page:e66
-
ISSN:0302-2838
-
Container-title:European Urology
-
language:en
-
Short-container-title:European Urology
Author:
Uleri AlessandroORCID,
Baboudjian Michael,
Diamand Romain,
Ploussard Guillaume
Reference4 articles.
1. Baboudjian M, Diamand R, Uleri A, et al. Does overgrading on targeted biopsy of magnetic resonance imaging–visible lesions in prostate cancer lead to overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.
2. Prostate cancer screening with PSA and MRI followed by targeted biopsy only;Hugosson;N Engl J Med,2022
3. Targeted prostate biopsy: umbra, penumbra, and value of perilesional sampling;Brisbane;Eur Urol,2022
4. Active surveillance for intermediate-risk prostate cancer: a systematic review, meta-analysis, and metaregression;Baboudjian;Eur Urol Oncol,2022